Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

836 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. Among authors: legendre c. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.
Rostaing L, Cantarovich D, Mourad G, Budde K, Rigotti P, Mariat C, Margreiter R, Capdevilla L, Lang P, Vialtel P, Ortuño-Mirete J, Charpentier B, Legendre C, Sanchez-Plumed J, Oppenheimer F, Kessler M; CARMEN Study Group. Rostaing L, et al. Among authors: legendre c. Transplantation. 2005 Apr 15;79(7):807-14. doi: 10.1097/01.tp.0000154915.20524.0a. Transplantation. 2005. PMID: 15818323 Clinical Trial.
Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function.
Russ G, Segoloni G, Oberbauer R, Legendre C, Mota A, Eris J, Grinyó JM, Friend P, Lawen J, Hartmann A, Schena FP, Lelong M, Burke JT, Neylan JF; Rapamune Maintenance Regimen Study Group. Russ G, et al. Among authors: legendre c. Transplantation. 2005 Nov 15;80(9):1204-11. doi: 10.1097/01.tp.0000178393.78084.9b. Transplantation. 2005. PMID: 16314787 Clinical Trial.
Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years.
Legendre C, Brault Y, Morales JM, Oberbauer R, Altieri P, Riad H, Mahony J, Messina M, Pussell B, Martínez JG, Lelong M, Burke JT, Neylan JF; Rapamune Maintenance Regimen Study Group. Legendre C, et al. Clin Transplant. 2007 May-Jun;21(3):330-6. doi: 10.1111/j.1399-0012.2007.00645.x. Clin Transplant. 2007. PMID: 17488381 Clinical Trial.
Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.
Hill GS, Nochy D, Bruneval P, Duong van Huyen JP, Glotz D, Suberbielle C, Zuber J, Anglicheau D, Empana JP, Legendre C, Loupy A. Hill GS, et al. Among authors: legendre c. J Am Soc Nephrol. 2011 May;22(5):975-83. doi: 10.1681/ASN.2010070777. Epub 2011 Apr 14. J Am Soc Nephrol. 2011. PMID: 21493773 Free PMC article.
Everolimus and long-term outcomes in renal transplantation.
Campistol JM, de Fijter JW, Nashan B, Holdaas H, Vítko S, Legendre C. Campistol JM, et al. Among authors: legendre c. Transplantation. 2011 Aug 15;92(3 Suppl):S3-26. doi: 10.1097/TP.0b013e3182230900. Transplantation. 2011. PMID: 21799392 No abstract available.
Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study.
Albano L, Alamartine E, Toupance O, Moulin B, Merville P, Rerolle JP, Tetaz R, Moal MC, Kamar N, Legendre C, Quéré S, Di Giambattista F, Terpereau A, Dantal J. Albano L, et al. Among authors: legendre c. Ann Transplant. 2012 Jan-Mar;17(1):58-67. doi: 10.12659/aot.882637. Ann Transplant. 2012. PMID: 22466910 Clinical Trial.
836 results